Clearside Biomedical Stock Current Valuation
| CLM Stock | EUR 1.01 0.04 4.12% |
Valuation analysis of Clearside Biomedical helps investors to measure Clearside Biomedical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Clearside Biomedical's price fluctuation is extremely dangerous at this time. Calculation of the real value of Clearside Biomedical is based on 3 months time horizon. Increasing Clearside Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Clearside Biomedical's intrinsic value may or may not be the same as its current market price of 1.01, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.01 | Real 0.9 | Hype 1.01 |
The intrinsic value of Clearside Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Clearside Biomedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Clearside Biomedical helps investors to forecast how Clearside stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Clearside Biomedical more accurately as focusing exclusively on Clearside Biomedical's fundamentals will not take into account other important factors: Clearside Biomedical Company Current Valuation Analysis
Clearside Biomedical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Clearside Biomedical Current Valuation | 17.17 M |
Most of Clearside Biomedical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clearside Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Clearside Biomedical has a Current Valuation of 17.17 M. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all Germany stocks is notably lower than that of the firm.
Clearside Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clearside Biomedical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clearside Biomedical could also be used in its relative valuation, which is a method of valuing Clearside Biomedical by comparing valuation metrics of similar companies.Clearside Biomedical is currently under evaluation in current valuation category among its peers.
Clearside Fundamentals
| Current Valuation | 17.17 M | |||
| Price To Book | 3.77 X | |||
| Price To Sales | 2.67 X | |||
| Revenue | 29.57 M | |||
| EBITDA | (449 K) | |||
| Net Income | 376 K | |||
| Cash Flow From Operations | (10.73 M) | |||
| Market Capitalization | 4.14 M | |||
| Total Asset | 42.9 M | |||
| Net Asset | 42.9 M |
About Clearside Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clearside Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearside Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearside Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clearside Stock Analysis
When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.